The importance of body composition in patients with prostate cancer receiving radiotherapy

Patients with nonmetastatic, high-risk prostate cancer are more likely to die of causes unrelated to their cancer. Identifying patients whose competing risks are a greater threat to their mortality has important implications for treatment decisions.

Automated summary

Patients with nonmetastatic, high-risk prostate cancer have a higher likelihood of dying from causes unrelated to their cancer. Identifying patients at greater risk from competing risks is crucial for treatment decision-making.